CA5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.897400E-01
Normal-vs-Stage2
2.141000E-01
Normal-vs-Stage3
1.697180E-01
Normal-vs-Stage4
9.468000E-01
Stage1-vs-Stage2
9.195800E-01
Stage1-vs-Stage3
1.124650E-01
Stage1-vs-Stage4
3.655200E-01
Stage2-vs-Stage3
1.197720E-03
Stage2-vs-Stage4
1.963020E-01
Stage3-vs-Stage4
1.617230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.241800E-01
Normal-vs-AfricanAmerican
7.671400E-01
Normal-vs-Asian
1.061560E-01
Caucasian-vs-AfricanAmerican
2.573600E-01
Caucasian-vs-Asian
2.524800E-01
AfricanAmerican-vs-Asian
1.169170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.020980E-01
Normal-vs-Female
5.014200E-01
Male-vs-Female
1.880490E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.065200E-01
Normal-vs-Age(41-60Yrs)
6.446200E-01
Normal-vs-Age(61-80Yrs)
1.349620E-01
Normal-vs-Age(81-100Yrs)
2.116100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.454600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.225200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.930150E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.958000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.035850E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.232800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.110370E-01
Normal-vs-Daily Drinker
6.711500E-02
Normal-vs-Weekly Drinker
1.937770E-01
Normal-vs-Occasional Drinker
1.737560E-01
Normal-vs-Social Drinker
7.176800E-01
Non Drinker-vs-Daily Drinker
8.188000E-01
Non Drinker-vs-Weekly Drinker
7.834000E-01
Non Drinker-vs-Occasional Drinker
5.627800E-01
Non Drinker-vs-Social Drinker
2.635400E-01
Daily Drinker-vs-Weekly Drinker
6.385200E-01
Daily Drinker-vs-Occasional Drinker
4.220800E-01
Daily Drinker-vs-Social Drinker
2.190400E-01
Weekly Drinker-vs-Occasional Drinker
8.229000E-01
Weekly Drinker-vs-Social Drinker
3.759600E-01
Occasional Drinker-vs-Social Drinker
4.322600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.629780E-01
Normal-vs-Grade 2
4.473600E-02
Normal-vs-Grade 3
6.395500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.575800E-01
Grade 1-vs-Grade 3
1.819570E-01
Grade 1-vs-Grade 4
1.629780E-01
Grade 2-vs-Grade 3
4.442400E-02
Grade 2-vs-Grade 4
4.473600E-02
Grade 3-vs-Grade 4
6.395500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.309610E-01
Normal-vs-NonDiabetic
2.273200E-01
Diabetic-vs-NonDiabetic
6.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.618400E-02
Normal-vs-NoPancreatitis
2.237000E-01
Pancreatitis-vs-NoPancreatitis
5.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.224800E-01
Normal-vs-N1
2.232600E-01
N0-vs-N1
9.763000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.830100E-02
Normal-vs-TP53-NonMutant
7.988600E-01
TP53-Mutant-vs-TP53-NonMutant
8.596700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
